Life Science REIT PLC Notice of Capital Markets Day (3428W)
17 April 2023 - 4:00PM
UK Regulatory
TIDMLABS
RNS Number : 3428W
Life Science REIT PLC
17 April 2023
17 April 2023
LEI: 213800RG7JNX7K8F7525
LIFE SCIENCE REIT PLC
(the "Company", "Life Science REIT" or, together with its
subsidiaries, the "Group")
Notice of Capital Markets Day
Life Science REIT (LSE: LABS), the real estate investment trust
focused on UK life science properties, is pleased to announce that
tomorrow, Tuesday 18 April 2023, it will host a capital markets day
for institutional investors and research analysts at London's
Francis Crick Institute, one of the foremost biomedical research
centres in the UK.
The event will include presentations by Ironstone Asset
Management, Life Science REIT's investment adviser, and by
specialists in life science company formation and development and
industry workplace design. Presenters will include Chris Hollowood,
the Chief Executive Officer of Syncona Investment Management, and
Jim Wilkinson, the Chief Financial Officer of Oxford Science
Enterprises. The event will include a panel discussion and a
Q&A session.
The event, on the morning of 18 April 2023, will be webcast live
from 10.00am via the following link:
https://stream.buchanan.uk.com/broadcast/642423ae03867fad45f7be52
Shareholders are invited to send any questions by email in
advance of the capital markets day to
lifesciencereit@buchanan.uk.com .
Following the event, a recording of the webcast will be made
available on the Company's website, https://lifesciencereit.co.uk
.
For further information, please contact Buchanan at
lifesciencereit@buchanan.uk.com .
No new price-sensitive information is expected to be announced
on the day.
Enquiries:
Link Company Matters Limited - Company
Secretary
labs_cosec@linkgroup.co.uk
Ironstone Asset Management - Investment
Adviser
Simon Farnsworth, Managing Director
Joanna Waddingham, Head of Investor Relations
and Corporate Affairs
Joanna.Waddingham@ironstoneam.com
Panmure Gordon (UK) Limited - Joint Corporate
Broker +44 20 7886 2500
Alex Collins / Tom Scrivens
Jefferies International Limited - Joint
Corporate Broker +44 20 7029 8000
Tom Yeadon / Andrew Morris / Oliver Nott
/ Harry Randall
G10 Capital Limited - AIFM +44 20 7397 5450
Verity Morgan-Jones / Paul Cowland
Buchanan - Financial PR +44 20 7466 5000
Mark Court / Henry Wilson / Verity Parker
LifeSciencereit@buchanan.uk.com
Notes to editors
Life Science REIT plc is a specialist property business focused
on the UK's growing life science sector. The Company's portfolio of
assets is located across the "Golden Triangle" of research and
development hubs in Oxford, Cambridge and London's Knowledge
Quarter and its strategic vision is to become the property provider
of choice for life science companies in the UK.
Life Science REIT is addressing the acute demand-supply
imbalance for laboratory space in the "Golden Triangle", which is
characterised by low vacancy rates and prime rental increases. The
UK life science sector itself is benefiting from a buoyant
early-stage funding environment, driving demand for laboratory
space.
The Company's diverse portfolio of assets ranges from a 20-acre
science park currently under development through to fully let
buildings, with an important part of the Company's strategy being
the conversion of existing properties to laboratory space.
The Company's investment policy is focused on capital growth
whilst also providing a growing level of income.
Life Science REIT trades on the Main Market of the London Stock
Exchange under the ticker LABS.
Further information is available at
https://lifesciencereit.co.uk . To sign up for email alerts, please
visit https://lifesciencereit.co.uk/investors/ .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCBCGDSGBBDGXL
(END) Dow Jones Newswires
April 17, 2023 02:00 ET (06:00 GMT)
Life Science Reit (LSE:LABS)
Historical Stock Chart
From Apr 2024 to May 2024
Life Science Reit (LSE:LABS)
Historical Stock Chart
From May 2023 to May 2024